Zanbato, Inc. – Trademark Portfolio
Entity Type: 03
Zanbato, Inc. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 14 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 10 trademarks are registered and 3 are pending. Notable registered marks include ZX, ZCHAT, ZXDATA, ZANBATO, and ZXALLIANCE. The owner is based in Mountain View, CA.
715 N. Shoreline Blvd.
Mountain View, CA 94043
Showing of trademarks Trademarks
Trademark Classifications
Zanbato, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Zanbato, Inc. have?
Zanbato, Inc. has 19 U.S. trademarks filed with the USPTO. Of these, 10 registered, 3 pending, 4 abandoned, 1 cancelled.
What trademark classes does Zanbato, Inc. file in?
Zanbato, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Zanbato, Inc.'s most well-known trademarks?
Zanbato, Inc.'s registered trademark portfolio includes well-known marks such as ZX, ZCHAT, ZXDATA, ZANBATO, and ZXALLIANCE. These are among 10 currently registered trademarks in the portfolio.
What is Zanbato, Inc.'s trademark registration success rate?
Zanbato, Inc. has a 67% trademark registration rate, with 10 out of 15 resolved applications resulting in successful registration. Currently, 3 applications are pending review.